Industry Marketing Research Products Market Research Founded 1989 | Key people Henry Gazay, CEO Website www.medimix.com Type of business Private | |
 | ||
Headquarters Miami, Florida, United States Profiles | ||
Medimix international season s greetings 2013
Medimix International is a global online-based market research company headquartered in Miami, Florida. The company was founded in 1989 in France, and moved its global headquarters to the United States in 2002. Medimix International is one of the pioneers in online marketing research for the lifescience industries, and has developed a proprietary panel of health care professionals since 1995.
Contents
- Medimix international season s greetings 2013
- Business specialization
- Performance
- Subsidiaries
- References
Medimix International is a member of the American Marketing Association (AMA), Pharmaceutical Business Intelligence Research Group (PBIRG), Pharmaceutical Marketing Research Group (PMRG) and the European Society for Opinion & Marketing Research (ESOMAR).
Business specialization
Medimix International specializes in the health care sector, working mainly for the pharmaceutical, biotech, and medical device industries. Medimix International offers qualitative and quantitative marketing research solutions, derived from a proprietary internet platform. Medimix International introduced different breakthroughs in Marketing research such as e-groups (online focus groups) e-charts (electronic patient charts) and Scanbuzz (Social media monitoring in the Healthcare sector).
Performance
Medimix International is a privately held company that experienced an organic growth rate of 15-20% through 2002-2005. In 2009, Medimix International derived 35% of its revenue from North America, 30% from Europe and 15% from Latin America. The Asia-Pacific region and the Middle East together accounted for 20% of revenues. In 2014 Medimix International launched LiveTracker, the first continuous prescription tracking in specialty pharmaceuticals. By the end of 2016, LiveTracker is available in 35 countries and 12 Therapeutic areas in Oncology, Hematology and Diabetes.